Fengqi Duan

1.1k total citations · 1 hit paper
11 papers, 756 citations indexed

About

Fengqi Duan is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Fengqi Duan has authored 11 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Nephrology. Recurrent topics in Fengqi Duan's work include Inflammasome and immune disorders (9 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Animal health and immunology (1 paper). Fengqi Duan is often cited by papers focused on Inflammasome and immune disorders (9 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Animal health and immunology (1 paper). Fengqi Duan collaborates with scholars based in China and Macao. Fengqi Duan's co-authors include Hongmei Tan, Cheng Zeng, Jia Hu, Hongyu Li, Xuanhong Zhang, Wancheng Chen, Lili Yu, Xiuting Sun, Zenghui Liu and Yang Xiao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Redox Biology.

In The Last Decade

Fengqi Duan

11 papers receiving 754 citations

Hit Papers

NLRP3 inflammasome-mediated pyroptosis contributes to the... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengqi Duan China 8 564 145 120 114 106 11 756
Ming-Hui Zheng China 16 399 0.7× 175 1.2× 67 0.6× 77 0.7× 62 0.6× 32 684
Gwennan André‐Grégoire France 17 432 0.8× 219 1.5× 127 1.1× 45 0.4× 109 1.0× 35 795
Luciana Aparecida Reis Brazil 9 483 0.9× 213 1.5× 69 0.6× 29 0.3× 130 1.2× 13 761
Siqi Yin China 9 507 0.9× 243 1.7× 61 0.5× 38 0.3× 107 1.0× 13 703
Carlos E. Irarrázabal Chile 20 486 0.9× 142 1.0× 115 1.0× 37 0.3× 189 1.8× 45 1.1k
Jiayi Yao China 21 618 1.1× 346 2.4× 102 0.8× 61 0.5× 88 0.8× 58 1.1k
Hongwen Zhang China 16 366 0.6× 66 0.5× 72 0.6× 50 0.4× 52 0.5× 67 731
Earl Poptic United States 14 320 0.6× 83 0.6× 153 1.3× 95 0.8× 104 1.0× 18 721
Sheng‐an Su China 15 453 0.8× 79 0.5× 113 0.9× 179 1.6× 82 0.8× 21 784
Chuan Wen China 15 465 0.8× 191 1.3× 170 1.4× 63 0.6× 64 0.6× 51 775

Countries citing papers authored by Fengqi Duan

Since Specialization
Citations

This map shows the geographic impact of Fengqi Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengqi Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengqi Duan more than expected).

Fields of papers citing papers by Fengqi Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengqi Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengqi Duan. The network helps show where Fengqi Duan may publish in the future.

Co-authorship network of co-authors of Fengqi Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Fengqi Duan. A scholar is included among the top collaborators of Fengqi Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengqi Duan. Fengqi Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Duan, Fengqi, et al.. (2024). Loss of Trim31 Worsens Cardiac Remodeling in a Mouse Model of Heart Failure by Enhancing the Activation of the NLRP3 Inflammasome. Inflammation. 48(4). 2650–2662. 1 indexed citations
2.
Duan, Fengqi, Li Li, Sijun Liu, et al.. (2024). Cortistatin protects against septic cardiomyopathy by inhibiting cardiomyocyte pyroptosis through the SSTR2-AMPK-NLRP3 pathway. International Immunopharmacology. 134. 112186–112186. 7 indexed citations
4.
Liu, Sijun, Ge Tang, Fengqi Duan, et al.. (2021). MiR-17-5p Inhibits TXNIP/NLRP3 Inflammasome Pathway and Suppresses Pancreatic β-Cell Pyroptosis in Diabetic Mice. Frontiers in Cardiovascular Medicine. 8. 768029–768029. 22 indexed citations
5.
Duan, Fengqi, Cheng Zeng, Sijun Liu, et al.. (2021). α1-nAchR-Mediated Signaling Through Lipid Raft Is Required for Nicotine-Induced NLRP3 Inflammasome Activation and Nicotine-Accelerated Atherosclerosis. Frontiers in Cell and Developmental Biology. 9. 724699–724699. 12 indexed citations
6.
7.
Zeng, Cheng, Fengqi Duan, Jia Hu, et al.. (2020). NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy. Redox Biology. 34. 101523–101523. 277 indexed citations breakdown →
8.
Hu, Jia, Jie Wei, Cheng Zeng, et al.. (2020). Z-ligustilide protects BV-2 microglial cells against oxygen-glucose deprivation/reoxygenation-induced injury by inhibiting NLRP3 inflammasome activation and pyroptosis. SHILAP Revista de lepidopterología. 18. 3254694324–3254694324. 1 indexed citations
9.
Tang, Ge, Fengqi Duan, Yiqin Wang, et al.. (2019). Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE−/− mice. Biomedicine & Pharmacotherapy. 119. 109410–109410. 59 indexed citations
11.
Chen, Wancheng, Yukai Huang, Jiaochan Han, et al.. (2016). Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunologic Research. 64(4). 831–840. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026